<DOC>
	<DOCNO>NCT00640484</DOCNO>
	<brief_summary>The purpose study confirm dose CHF 4226 ( carmoterol ) give day patient COPD order effect last 24 hour .</brief_summary>
	<brief_title>Confirmatory Dose Finding Study 2 Dosages CHF 4226 pMDI ( Carmoterol ) Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Signed IRB approve Informed Consent form Male nonpregnant female , 40 75 year old , inclusive Current past cigarette smoke history least 15 packyears Clinical diagnosis COPD accordance recommendation National Heart Lung Blood Institute/World Health Organization ( NHLBI/WHO ) Global Initiative Chronic Obstructive Lung Disease ( GOLD ) Patient meet follow requirement FEV1 albuterol reversibility test ( i.e. , 30 minute 200μg ( meter dose ) albuterol MDI ) : FEV1/FVC &lt; 70 % FEV1 least 0.9L FEV1 30 % 80 % , inclusive , patient 's predict normal value ; ∆FEV1 &gt; 5 % prealbuterol value If ∆FEV1 &lt; 5 % prealbuterol value , requirement must meet retesting runin period , least 24 hour prior Period 1/Visit 1 . History asthma Blood eosinophil count &gt; 500/microliters History allergic rhinitis atopy COPD exacerbation lower respiratory tract infection within 8 week prior screen , runin period , result use antibiotic , oral parenteral corticosteroid Inhaled corticosteroid initiate , effective dose change , within 4 week prior screen runin period Uncontrolled cardiovascular ( e.g. , uncontrolled hypertension ) , respiratory , hematologic , immunologic , renal , neurologic , hepatic , endocrine ( e.g. , uncontrolled diabetes mellitus ) disease , condition might , Investigator 's judgment , place patient undue risk potentially compromise study result interpretation History coronary artery disease , cerebrovascular disease , cardiac arrhythmia Lung cancer history lung cancer Active cancer history cancer &lt; 5 year disease free survival time ( without evidence local recurrence metastasis ) . Localized basal cell carcinoma ( without metastasis ) skin acceptable . Serum potassium value ≤ 3.5 mEq/L &gt; 5.5mEq/L and/or fast serum glucose value ≥ 140 mg/dL Abnormal QTcF interval value Screening visit ECG test ( i.e. , &gt; 450 msec male &gt; 470 msec female ) Cor Pulmonale Long term oxygen therapy , i.e. , &gt; 16 hours/24hour period , every day , unless patient resides elevation &gt; 4000ft Use follow medication prior Screening , without meet specify minimum washout period : Long act anticholinergic agent ( i.e. , tiotropium ) : 7 day Short act anticholinergic : 8 hour Fixed combination β2agonists inhale corticosteroid : 48 hour Fixed combination anticholinergic short act β2agonist : 8 hour Longacting β2agonists : 48 hour Short act β2agonists ( prescribe study ) : 6 hour Theophylline xanthine : 1 week Parenteral oral corticosteroid : 1 month Patient take nonpermitted medication Patient receive liveattenuated virus vaccination within two week prior screen runin ( inactivated Influenza vaccination acceptable give &gt; 48 hour prior Screening ) Known intolerance/hypersensitivity β2adrenergic agonist , propellant gases/excipients Patient pregnant lactate female , female risk pregnancy ( i.e. , use adequate contraceptive method : surgical sterilization [ e.g. , bilateral tubal ligation ] , hormonal contraception [ implantable , patch , oral ] , IUD , doublebarrier method [ double combination : male female condom spermicidal gel , diaphragm , sponge , cervical cap ] ) . Patient mentally legally incapacitated Patient participate another investigational study within 30 day prior screen Abuse alcohol substance Patient maintain regular day/night , waking/sleeping cycle ( e.g. , night shift worker ) Patient potentially noncompliant unable perform require protocol outcome measurement</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>